Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000215305 | SCV000269001 | benign | not specified | 2015-10-12 | criteria provided, single submitter | clinical testing | p.Ile1718Val in exon 30 of DNAH11: This variant is not expected to have clinical significance because it has been identified in 2.0% (90/4388) of East Asian chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs137855415). |
Illumina Laboratory Services, |
RCV000299427 | SCV000468110 | uncertain significance | Primary ciliary dyskinesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000299427 | SCV000750528 | benign | Primary ciliary dyskinesia | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000299427 | SCV002644827 | benign | Primary ciliary dyskinesia | 2016-04-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004541307 | SCV004782398 | benign | DNAH11-related disorder | 2019-08-14 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |